Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series

BACKGROUND: Leukotriene receptor antagonists (LTRAs) are widely used for asthma and allergic rhinitis (AR), but concerns about the risk of neuropsychiatric events (NPEs) have been raised since the first Drug Safety Communication by the US Food and Drug Administration in 2008. This study evaluates th...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Ji Soo, Cho, Yoo Jung, Yun, Je-Yeon, Lee, Hye Jin, Yu, Jinho, Yang, Hyeon-Jong, Suh, Dong In
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630607/
https://www.ncbi.nlm.nih.gov/pubmed/35595323
http://dx.doi.org/10.1183/13993003.02467-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630607/
https://www.ncbi.nlm.nih.gov/pubmed/35595323
http://dx.doi.org/10.1183/13993003.02467-2021

Ejemplares similares